REFERENCES
- Denton MD, Davis SF, Baum MA, Melter M, Reinders ME, Exeni A, Samsonov DV, Fang J, Ganz P, Briscoe DM. The role of the graft endothelium in transplant rejection: evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection. Pediatr. Transplant 2000; 4: 252–260, [INFOTRIEVE], [CSA]
- Ozdemir BH, Ozdemir FN, Gungen Y, Haberal M. Role of macrophages and lymphocytes in the induction of neovascularization in renal allograft rejection. Am. J. Kidney Dis 2002; 39: 347–353, [INFOTRIEVE], [CSA]
- Meyer D, Girma JP. von Willebrand factor: structure and function. Thromb. Hemost 1993; 70: 99–104, [CSA]
- Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Wiebel-Palade bodies of human endothelial cells. J. Cell Biol 1982; 95: 355–360, [INFOTRIEVE], [CSA], [CROSSREF]
- Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 1986; 46: 185–190, [INFOTRIEVE], [CSA], [CROSSREF]
- Sato M, Koshikawa S, Arakawa M. Glomerular deposition of antihemophilic factor antigen in various renal diseases. Clin. Nephrol 1981; 15: 80–86, [INFOTRIEVE], [CSA]
- Lagoo AS, Buckley PJ, Burchell LJ, Peters D, Fechner JH, Tsuchida M, Dong Y, Hong X, Brunner KG, Oberley TD, Hamawy MM, Knechtle SJ. Increased glomerular deposits of von Willebrand factor in chronic, but not acute, rejection of primate renal allografts. Transplantation 2000; 70: 877–886, [INFOTRIEVE], [CSA], [CROSSREF]
- Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y, et al. The Banff 97 working classification of renal allografts pathology. Kidney Int 1999; 55: 713–723, [INFOTRIEVE], [CSA], [CROSSREF]
- Monga G, Mazzucco G, Novara R, Reale L. Intertubular capillary changes in kidney allografts: an ultrastructural study in patients with transplant glomerulopathy. Ultrastruct. Pathol 1990; 14: 201–209, [INFOTRIEVE], [CSA]
- Kiyici H, Demirhan B, Özdemir BH, Aktaş G, Karabay G, Haberal M. Significance of peritubular capillary basement membrane multilamellation in diagnosis of chronic allograft nephropathy. Transplant Proc 2003; 35: 2643–2644, [INFOTRIEVE], [CSA], [CROSSREF]
- Schlondorff D, Nelson PJ, Luckow B, Banas B. Chemokines and renal disease. Kidney Int 1997; 51: 610–621, [INFOTRIEVE], [CSA]
- Özdemir BH, Demirhan B, Gungen Y. The presence and prognostic importance of glomerular macrophage infiltration in renal allografts. Nephron 2002; 90: 442–446, [CSA], [CROSSREF]
- Pichler R, Giachelli C, Young B, Alpers CE, Couser WG, Johnson RJ. The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: the glomerular cytokine theory. Miner. Electrolyte Metab 1995; 21: 317–327, [INFOTRIEVE], [CSA]
- Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J. Leuk. Biol 1994; 55: 410–422, [CSA]
- Floege J, Eng E, Young BA, Couser WG, Johnson RJ. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 1993; 43: 369–380, [INFOTRIEVE], [CSA]
- Gradowska L, Lao M, Morzycka-Michalik M, Gorski A. Low dose heparin: efficacious treatment for chronic renal allograft rejection. Arch. Immunol. Ther. Exp. (Warz) 1993; 41: 133–135, [CSA]
- Krzossok S, Birck R, Koeppel H, Schnulle P, Waldherr R, van der Wounde FJ, Braun C. Treatment of proteinuria with low-molecular weight heparin after renal transplantation. Transplant Int 2004; 17: 468–472, [CSA]
- van der Pijl JW, van der Woude FJ, Geelhoed-Dujvestijn PH, Fröhlich M, van der Meer FJ, Lemkes HH, van Es LA. Danaparoid sodium lowers proteinuria in diabetic nephropathy. J. Am. Soc. Nephrol 1997; 8: 456–462, [INFOTRIEVE], [CSA]
- Ceol M, Vianello D, Schleicher E, Anglani F, Barbanti M, Bonfante L, Bertaglia G, Graziotto R, D'Angelo A, Del Prete D, Gambaro G. Heparin reduces glomerular infiltration and TGF-β protein expression by macrophages in puromycin glomerulosclerosis. J. Nephrol 2003; 16: 210–218, [INFOTRIEVE], [CSA]
- Braun C, Schultz M, Fang L, Schaub M, Back WE, Herr D, Laux V, Rohmeiss P, Schnuelle P, van der Woude FJ. Treatment of chronic renal allograft rejection in rats with a low-molecular weight heparin (Reviparin). Transplantation 2001; 72: 209–215, [INFOTRIEVE], [CSA], [CROSSREF]